Mikhail Blagosklonny is a competent scientist, lecturer, innovator, and author. Mikhail Blagosklonny lectures oncology at the New York-based Roswell Park Cancer Institute. He studies signal transduction, cellular biology, anticancer therapeutics, cellular senescence, and cell cycle. He has built an exciting career in the field of research.
Education and career history
Blagosklonny attended the First Pavlov State Medical University of St. Petersburg and earned his Master’s degree in internal medicine. Later on, he graduated with a doctorate’s degree in cardiology and experimental medicine from the same university. In 2002, the Valhalla, NY-based New York Medical College appointed him as the associate professor in charge of the medical department. A few months later, Mikhail Blagosklonny landed another distinguished appointment from Ordway Research Institute headquartered in Albany, New York to serve as a senior scientist. He relinquished his position in 2009 and joined Roswell Park Cancer Institute as the oncology’s professor.
Mikhail Blagosklonny is one of the founders of Cell Cycle and serves as its editor-in-chief. He is an associate editor of Cancer Research, Autophagy, American Journal of Pathology, Cell Death & Differentiation, and International Journal of Cancer Research. He was responsible for advancing the research on signal transduction paths from cancer to aging. He also revealed a potential target for lowering the rate of aging and diseases associated with aging.
Read more: Distinguished physician-scientist, Dr. Mikhail Blagosklonny, joins Roswell Park Cancer Institute
Appointment at Roswell Park Cancer Institute
Roswell Park’s senior VP in charge of basic science, Andrei V. Gudkov, said that Mikhail Blagosklonny is an accomplished researcher who introduced innovative concepts in cancer biology and its treatment. He added that Blagosklonny would assist in developing new anticancer concepts and strategies of cancer treatment and prevention. The researcher will utilize Roswell Park’s ideas and strategies such as preventing radio and chemotherapy from damaging healthy cells, tissue-specific therapy, and averting cancer by lowering the rate of organismal aging, to come up with more efficient cancer treatments.
Apart from leading the fight against cancer, Blagosklonny has been conducting intensive researches on underlying aging mechanisms. His mission is to develop medications that can slow down the rate of aging. Therefore, Blagosklonny has come up with a hypothesis concerning the possibility of using TOR signaling in slowing down aging and cancer therapy. He has proposed the use of rapamycin, a renowned cancer medication, as a potential anti-aging drug. Blagosklonny is recognized across the globe as one of the most passionate supporters of rapamycin in life extension research. He has authored and published over 270 scientific papers with more than 25,000 citations.
Review publishing of Mikhail Blagosklonny on Impact Journals
Read more about Mikhail Blagosklonny on Nature
James Dondero is an American investment expert and co-founder of Highland Capital Management. He cherishes charity work by donating to community-based and other nonprofit organizations. Dondero recently supported The Family Place by donating a grant valued at one million dollars.
The grant is supposed to help The Family Place in constructing a facility for housing family violence victims as well as offering counseling services to them. Dondero announced the news as he attended the nonprofit organization’s Texas Trailblazer Awards Luncheon that took place in Dallas TX.
Highland Capital Management supports nonprofit organizations through its philanthropic subsidiary known as Highland Dallas Foundation. The Family Place will receive the grant through Highland Dallas Foundation. This nonprofit organization had previously raised $200,000 to support its Legacy Campaign. The organization aims at raising a total of $2.8 million for the campaign.
Speaking at the luncheon, James Dondero appreciated the efforts of The Family Place and other government officials from Dallas such as the mayor and police chief. He pointed out ways in which the grant will mitigate life-threatening social issues that affect the residents of Dallas. Paige Flink, the chief executive officer of The Family Place also encouraged people to support the organization.
About James Dondero
James Dondero currently manages Highland Capital Management as the president. He also lives in Dallas where the company is headquartered. Dondero has worked in credit and equity markets for more than 30 years.
He attended the McIntyre School of Commerce for dual degrees in accounting and finance. His expertise also lies in high-yield and distressed investing. Highland Capital Management officially began its operations in 1993. Since its establishment, Dondero was instrumental in developing the Collateral Loan Obligation. He also developed credit solutions for retail and institutional investors.
Dondero seats on the executive boards of Nexbank, Cornerstone Health and CCS Medical as the chairperson. Dondero is a certified management accountant and also a registered Chartered Financial Analyst. As an investment officer, he is renowned for helping a branch of Protective Life to amass $2.8 billion in revenue. His charity work revolves around education, public policy, as well as veteran affairs.
Just recently, the Davos Real Estate Group introduced their Davos CAP Calculator, an app that helps both current and prospective clients to calculate the potential return on real estate investment property. The app is available on both the iPhone and Android platforms and it assists the investor to quickly calculate the potential rent compared to the purchase price of the property.
The Davos Real Estate Group is under the wing of the Davos Financial Group, a multinational investment company owned and operated by David Osio, a long time success in the investment community of several continents and countries of the world.
Mr. Osio has a long and successful history of holding key investment positions in the investment banking industry, investment law, and as the President and CEO of several major investment companies both in Latin America, North America, and Europe.
His entire training and industry focus has been in the diversified investment community, and he is well-known on a worldwide basis for his wisdom and investment knowledge. After having spent a good deal of time running other people’s companies, in 1993, Mr. Osio decided to form his company, and that is how The Davos companies were born.
Starting in Venezuela, Mr. Osio organized his company to only works with a select group of clients as far as offering financial advice. This allowed Mr. Osio and his colleagues the opportunity to fine-tune procedures and determine what worked well and what did not.
This process allowed Mr. Osio the chance to form a leadership team who took on the advent of attracting a larger group of clients and the business prospered and grew. The object of tailoring each financial campaign to the needs, resources and objectives of each client was the system that set Davos apart from the competition.
Each separate financial company is formed under the umbrella of Davos Financial Group and is distinctive to each investor’s individual needs as he or she walks the path of investment management with the various advisors assigned to them.
Since Davos keeps tabs on investments on a worldwide basis, there is an unlimited choice of what types of investments will fit investors who come to Davos for advice. This strategy not only allows for great diversification, but investments are available in niches that would possibly not be available if the scope was limited to just one country.
The Davos CAP calculator is just one tool that aids investors and advisors alike, as the Davos Financial Group reaches out to more and more clients all over the world.